Rituximab and Subcutaneous 2-Chloro-2'-Deoxyadenosine Combination Treatment for Patients With Waldenstrom Macroglobulinemia: Clinical and Biologic Results of a Phase II Multicenter Study
Laszlo, D., Andreola, G., Rigacci, L., Fabbri, A., Rabascio, C., Mancuso, P., Pruneri, G., Radice, D., Pinto, A., Frigeri, F., Calabrese, L., Billio, A., Bertolini, F., Martinelli, G.Volume:
28
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2009.23.6315
Date:
May, 2010
File:
PDF, 125 KB
english, 2010